
Mitok Bio
觅投克生物
Mitok Bio
Biotech/Healthcare
Mitouke Biotech develops stem cell therapies for age-related diseases in companion animals. It primarily develops mesenchymal stem cell (MSC) therapies for elderly cats and dogs, targeting indications including muscle atrophy, inflammatory bowel disease, and osteoarthritis.
Latest round: Pre Series A (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.